FDA grants Reddy’s a Duvvada reinspection

Dr Reddy’s has had its request for a US Food and DrugAdministration (FDA) reinspection of its oncology formulations plant in Duvvada, India, granted by the US agency. As Generics bulletin went to press, eight ‘Form 483’ observations were announced.